TAMRA-PEG4-Methyltetrazine: Protocol & Applications Guide

TAMRA-PEG4-Methyltetrazine is a cell-permeable, fluorescent bioorthogonal probe that combines the bright orange-red TAMRA fluorophore with a reactive methyltetrazine group via a water-solubilizing PEG4 linker, enabling rapid and highly selective covalent labeling of trans-cyclooctene (TCO)- or norbornene-tagged biomolecules through inverse-electron-demand Diels-Alder (IEDDA) cycloaddition.

Catalog SKU

T595721

Reaction Type

Inverse-electron-demand Diels-Alder (IEDDA) cycloaddition

Reactive Partner

trans-Cyclooctene (TCO) and norbornene dienophiles

Fluorophore

TAMRA (tetramethylrhodamine); excitation ~545 nm, emission ~572 nm

Linker

PEG4 (tetraethylene glycol), improves aqueous solubility

Recommended Storage

-20 °C, protected from light, desiccated

Typical Working Concentration

0.1–10 µM (application-dependent; verify empirically)

Principle and Background

TAMRA-PEG4-Methyltetrazine belongs to the family of bioorthogonal tetrazine probes designed for covalent, chemoselective labeling of biomolecules in complex biological environments. The core chemistry is the inverse-electron-demand Diels-Alder (IEDDA) cycloaddition between the electron-poor 1,2,4,5-tetrazine (Tz) ring and strained dienophiles such as trans-cyclooctene (TCO) or norbornene. This reaction is exceptionally fast (rate constants up to 10⁴–10⁶ M^-1s^-1 for TCO pairs), proceeds without a catalyst, generates only N₂ as a by-product, and is fully orthogonal to native cellular chemistry.

The methyltetrazine variant offers improved chemical stability relative to unsubstituted tetrazine while retaining high reactivity toward strained dienophiles. The PEG4 spacer enhances aqueous solubility and reduces nonspecific adsorption, making the probe suitable for live-cell and in vitro assays. The TAMRA fluorophore (λ_ex ≈ 545 nm, λ_em ≈ 572 nm) provides a bright orange-red signal compatible with standard TRITC or Cy3 filter sets on fluorescence microscopes and flow cytometers.

Reagent Preparation and Stock Solution

Materials required: TAMRA-PEG4-Methyltetrazine (T595721), anhydrous DMSO (≥99.9%), amber microcentrifuge tubes, dry ice or liquid nitrogen, and appropriate aqueous buffer (e.g., PBS pH 7.4).

1. Reconstitution: Allow the vial to equilibrate to room temperature inside a desiccator before opening to avoid moisture condensation. Dissolve the compound in anhydrous DMSO to prepare a concentrated stock solution (e.g., 1–10 mM). Vortex briefly and sonicate if necessary to ensure complete dissolution.
2. Stock concentration verification: Confirm stock concentration by UV-Vis absorbance using the TAMRA extinction coefficient (ε ≈ 95,000 M^-1cm^-1 at ~545 nm). Adjust the value according to the Certificate of Analysis supplied with the product.
3. Aliquoting: Divide the stock into single-use aliquots in amber tubes under low-actinic light to minimise photobleaching. Snap-freeze aliquots in liquid nitrogen.
4. Storage: Store aliquots at −20 °C, desiccated and protected from light. Avoid repeated freeze–thaw cycles. DMSO stocks are typically stable for ≥6 months under these conditions.
5. Working solution: Dilute the DMSO stock into aqueous buffer or cell culture medium immediately before use. Keep the final DMSO content ≤1% (v/v) for cell-based assays.

Note: All specific stability figures and extinction coefficient values should be confirmed against the product Certificate of Analysis (CoA) provided by Aladdin Scientific.

Bioorthogonal Labeling Protocol

The following general protocol describes labeling of a TCO-modified target (protein, nucleic acid, or small molecule) with TAMRA-PEG4-Methyltetrazine. Adjust incubation times and concentrations according to the specific application.

A. In vitro protein labeling

1. Prepare the TCO-modified protein of interest at the desired concentration in PBS or compatible buffer.
2. Add TAMRA-PEG4-Methyltetrazine from the DMSO stock to a final concentration of 1–5 equivalents relative to the TCO-tagged substrate (or as empirically optimised).
3. Incubate at room temperature for 30–60 minutes with gentle mixing. The IEDDA reaction is typically complete within minutes for TCO partners, but longer incubation ensures maximum labeling efficiency.
4. Remove excess unreacted probe by size-exclusion chromatography, dialysis, or spin desalting columns.
5. Analyze labeling efficiency by SDS-PAGE with in-gel fluorescence scanning or by absorbance ratio (A₅₄₅/A₂₈₀).

B. Live-cell surface labeling

1. Culture cells expressing a TCO-modified surface protein (e.g., via genetic code expansion or metabolic labeling) to 70–90% confluency.
2. Wash cells twice with warm PBS.
3. Add TAMRA-PEG4-Methyltetrazine at 0.1–1 µM in serum-free medium or PBS. Incubate at 37 °C for 10–30 minutes.
4. Wash cells 3× with PBS to remove unbound probe.
5. Image immediately using a TRITC or Cy3 filter set (λ_ex 545 nm / λ_em 572 nm), or fix with 4% paraformaldehyde for downstream immunofluorescence.

Important: Optimise probe concentration and incubation time empirically for each cell type and target. High probe concentrations may increase background fluorescence.

Troubleshooting and Optimization Tips

Use the table below as a reference when troubleshooting common issues encountered with TAMRA-PEG4-Methyltetrazine labeling experiments.

Issue	Possible Cause	Recommended Action
Low or absent fluorescent signal	Probe degradation; insufficient TCO density; short incubation	Verify probe integrity by UV-Vis; increase probe concentration; extend incubation time
High background / nonspecific staining	Excess unbound probe; probe aggregation	Increase washing steps; reduce probe concentration; add 0.1% BSA to wash buffer
Poor aqueous solubility	Insufficient DMSO predissolution	Ensure complete dissolution in DMSO before aqueous dilution; vortex and sonicate
Rapid signal loss during imaging	TAMRA photobleaching	Minimise light exposure; use an antifade mounting medium; image promptly
Inconsistent results between experiments	Freeze–thaw degradation; variable TCO density on target	Use single-use aliquots; standardise TCO-modification protocol

Tetrazine probes are sensitive to nucleophiles and oxidants. Avoid buffers containing thiol reagents (e.g., DTT, β-mercaptoethanol) or high concentrations of reducing agents, as these may degrade the tetrazine ring and reduce reactivity.

Safety, Disposal, and Quality Notes

Safety: TAMRA-PEG4-Methyltetrazine is intended for research use only. It is not approved for diagnostic, therapeutic, or veterinary use. Handle with standard laboratory precautions: wear appropriate PPE (gloves, lab coat, eye protection). Avoid inhalation of DMSO solutions. DMSO can enhance dermal absorption of dissolved compounds.

Disposal: Dispose of all waste materials in accordance with local institutional and governmental regulations for chemical and biological waste. DMSO waste should be collected separately and disposed of as chemical waste.

Quality control: Each lot is characterised by the manufacturer. Confirm identity, purity, and concentration using the Certificate of Analysis (CoA) provided with shipment. For critical experiments, verify probe activity by reacting an aliquot with a TCO standard and monitoring fluorescence or mass shift.

Shipping: The compound is typically shipped with a cool pack. Upon receipt, transfer to −20 °C storage immediately.

Frequently asked questions

What reactive partners are compatible with TAMRA-PEG4-Methyltetrazine?

TAMRA-PEG4-Methyltetrazine reacts selectively with strained dienophiles via inverse-electron-demand Diels-Alder cycloaddition. The primary partners are trans-cyclooctene (TCO) derivatives, which offer the fastest reaction kinetics, and norbornene-tagged molecules, which react more slowly. These groups can be installed on proteins, nucleic acids, lipids, or small molecules through chemical synthesis or genetic code expansion.

Can TAMRA-PEG4-Methyltetrazine be used in live-cell experiments?

Yes. The PEG4 linker improves aqueous solubility and reduces nonspecific membrane interactions, and TAMRA-based probes are generally compatible with live-cell fluorescence imaging. The IEDDA reaction proceeds under physiological conditions without the need for toxic catalysts or external stimuli. Optimal probe concentration and incubation conditions should be validated empirically to minimize cytotoxicity and background signal.

Why is my TAMRA-PEG4-Methyltetrazine probe showing reduced reactivity?

Reduced reactivity is most commonly caused by tetrazine ring degradation due to moisture, light exposure, repeated freeze-thaw cycles, or the presence of thiol-containing reagents (e.g., DTT) in the reaction buffer. To preserve probe integrity, store aliquots at −20 °C in anhydrous DMSO, protected from light, and avoid thiol-containing buffers. If degradation is suspected, verify by UV-Vis spectroscopy — a decrease in the characteristic tetrazine absorbance (~520 nm) relative to the TAMRA peak indicates degradation.

What fluorescence filter set should I use to detect TAMRA?

TAMRA has excitation maximum near 545 nm and emission maximum near 572 nm. Standard TRITC or Cy3 filter sets available on most fluorescence microscopes and flow cytometers are well-suited for TAMRA detection. Confirm the exact spectral specifications against the product CoA, as the precise peak wavelengths can vary slightly depending on the chemical environment.

How should I remove excess unreacted TAMRA-PEG4-Methyltetrazine after labeling?

Excess probe can be removed by size-exclusion chromatography (e.g., Sephadex G-25 or equivalent desalting columns), dialysis against the appropriate buffer, or centrifugal filter units with a molecular weight cutoff appropriate for the labeled target. For cell-based assays, thorough washing with PBS (at least 3 times) is typically sufficient to remove unbound probe from the cell surface.

References

1. Blackman, M. L.; Royzen, M.; Fox, J. M. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. Journal of the American Chemical Society, 2008, 130(41), 13518–13519. doi:10.1021/ja8053805
2. Devaraj, N. K.; Weissleder, R.; Hilderbrand, S. A. Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjugate Chemistry, 2008, 19(12), 2297–2299. doi:10.1021/bc8004446
3. Knall, A.-C.; Slugovc, C. Inverse electron demand Diels-Alder (iEDDA)-initiated conjugation: a (high) potential click chemistry scheme. Chemical Society Reviews, 2013, 42(12), 5131–5142. doi:10.1039/c3cs60049a

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.